Insiders · CAMP

CAMP insider transactions

CAMP4 Therapeutics Corporation (CAMP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CAMP

• 4d
  Director Schwab Andrew J. sold $879,719 worth of shares (191,865 units at $4.59) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 6d
  Chief Scientific Officer Tardiff Daniel sold $8,273 worth of shares (1,738 units at $4.76), closing all direct ownership in the company (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 20d
  SEC Form 4 filed by Large owner 5am Partners Vi, Llc

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 20d
  SEC Form 4 filed by Director Schwab Andrew J.

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 20d
  Director Young Richard A bought $27,024 worth of shares (16,378 units at $1.65), increasing direct ownership by 10% to 186,388 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 20d
  Chief Medical Officer Maricich Yuri bought $10,809 worth of shares (6,551 units at $1.65), increasing direct ownership by 108% to 12,611 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 20d
  Chief Financial Officer Gold Kelly bought $10,809 worth of shares (6,551 units at $1.65), increasing direct ownership by 10% to 74,428 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 20d
  Chief Executive Officer Mandel-Brehm Josh bought $10,809 worth of shares (6,551 units at $1.65), increasing direct ownership by 2% to 284,968 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 74d
  SEC Form 4 filed by Director Young Richard A

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 74d
  SEC Form 4 filed by Director Schwab Andrew J.

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 74d
  SEC Form 4 filed by Director Williams Douglas E

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 74d
  SEC Form 4 filed by Director Holtzman Steven H

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 74d
  SEC Form 4 filed by Director Stewart Murray

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 74d
  SEC Form 4 filed by Director Nashat Amir

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 144d
  SEC Form 4 filed by Tardiff Daniel

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 144d
  SEC Form 4 filed by Maricich Yuri

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 144d
  SEC Form 4 filed by Gold Kelly

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 144d
  SEC Form 4 filed by Mandel-Brehm Josh

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 144d
  SEC Form 4 filed by Maclean Michael F

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 144d
  SEC Form 3 filed by new insider Maclean Michael F

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 246d
  SEC Form 4 filed by Chief Scientific Officer Tardiff Daniel

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 246d
  SEC Form 4 filed by Chief Medical Officer Maricich Yuri

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 246d
  SEC Form 4 filed by Chief Financial Officer Gold Kelly

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 246d
  SEC Form 4 filed by Chief Executive Officer Mandel-Brehm Josh

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 319d
  SEC Form 3 filed by new insider Tardiff Daniel

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 344d
  Director Schwab Andrew J. was granted 2,941,176 shares (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 344d
  Large owner 5am Partners Vi, Llc bought $4,499,999 worth of shares (2,941,176 units at $1.53) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 348d
  Large owner Polaris Management Co. Vii, L.L.C. bought $1,999,999 worth of shares (1,307,189 units at $1.53) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 348d
  Director Nashat Amir bought $1,999,999 worth of shares (1,307,189 units at $1.53) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 348d
  Chief Medical Officer Maricich Yuri bought $9,999 worth of shares (6,060 units at $1.65) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 348d
  Chief Financial Officer Gold Kelly bought $9,999 worth of shares (6,060 units at $1.65), increasing direct ownership by 10% to 67,877 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 348d
  Chief Executive Officer Mandel-Brehm Josh bought $9,999 worth of shares (6,060 units at $1.65), increasing direct ownership by 2% to 278,417 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 348d
  Director Young Richard A bought $24,999 worth of shares (15,151 units at $1.65), increasing direct ownership by 10% to 170,010 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 424d
  SEC Form 4 filed by Director Nashat Amir

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 424d
  SEC Form 4 filed by Director Young Richard A

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 424d
  SEC Form 4 filed by Director Holtzman Steven H

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 424d
  SEC Form 4 filed by Director Boylan James P

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 424d
  SEC Form 4 filed by Director Schwab Andrew J.

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 424d
  SEC Form 4 filed by Director Higgins Michael J

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 424d
  SEC Form 4 filed by Director Ragan Paula

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 424d
  SEC Form 4 filed by Director Thadhani Ravi I.

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 509d
  SEC Form 4 filed by Chief Scientific Officer Bumcrot David

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 509d
  SEC Form 4 filed by Chief Medical Officer Maricich Yuri

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 509d
  SEC Form 4 filed by Chief Financial Officer Gold Kelly

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 509d
  SEC Form 4 filed by Chief Executive Officer Mandel-Brehm Josh

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 524d
  SEC Form 4 filed by Director Williams Douglas E

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 524d
  SEC Form 4 filed by Director Stewart Murray

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 524d
  SEC Form 3 filed by new insider Williams Douglas E

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 524d
  SEC Form 3 filed by new insider Stewart Murray

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 672d
  Amendment: Large owner Polaris Management Co. Vii, L.L.C. converted options into 1,715,972 shares and bought $9,999,990 worth of shares (909,090 units at $11.00) (SEC Form 4)

  4/A - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 672d
  Amendment: New insider Polaris Partners Gp X, L.L.C. claimed ownership of 909,090 shares (SEC Form 3)

  3/A - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 677d
  Large owner Northpond Ventures Ii Gp, Llc converted options into 1,474,608 shares and bought $8,399,996 worth of shares (763,636 units at $11.00) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 677d
  Large owner Ah Equity Partners Bio I, L.L.C. converted options into 1,398,067 shares and bought $7,999,992 worth of shares (727,272 units at $11.00) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 677d
  Large owner Enavate Sciences Gp, Llc converted options into 2,422,166 shares and bought $14,999,996 worth of shares (1,363,636 units at $11.00) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 679d
  Large owner Polaris Management Co. Vii, L.L.C. converted options into 1,715,972 shares and bought $9,999,990 worth of shares (909,090 units at $11.00) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 679d
  Large owner 5am Partners Vi, Llc converted options into 2,018,825 shares and bought $9,999,990 worth of shares (909,090 units at $11.00) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 679d
  Director Nashat Amir bought $9,999,990 worth of shares (909,090 units at $11.00) and converted options into 1,715,972 shares (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 679d
  Director Schwab Andrew J. bought $9,999,990 worth of shares (909,090 units at $11.00) and converted options into 2,018,825 shares (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 679d
  Director Holtzman Steven H converted options into 8,917 shares, increasing direct ownership by 9% to 108,946 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 679d
  Director Young Richard A converted options into 8,917 shares, increasing direct ownership by 6% to 154,859 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)